{固定描述} Biotechnology and pharmaceutical shares have come under pressure recently as investors shift capital into energy equities, according to a report from Barron’s. The rotation reflects changing market sentiment and may be tied to evolving macroeconomic conditions, though no specific catalyst was cited.
Biotech and Pharma Stocks Slide as Capital Rotates Toward Energy Sector - {财报副标题}
© 2026 Market Analysis. All data is for informational purposes only.